Selective in vivo targeting of human liver tumors by optimized AAV3 vectors in a murine xenograft model
about
Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinomaLiver-targeted gene therapy: Approaches and challengesEvaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine modelsShikonin Induces Apoptosis, Necrosis, and Premature Senescence of Human A549 Lung Cancer Cells through Upregulation of p53 ExpressionEfficient and Targeted Transduction of Nonhuman Primate Liver With Systemically Delivered Optimized AAV3B Vectors.Comparative Study of Liver Gene Transfer With AAV Vectors Based on Natural and Engineered AAV Capsids.Strategies to generate high-titer, high-potency recombinant AAV3 serotype vectorsSuperior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid.Adeno-associated virus (AAV) vectors in cancer gene therapy.Metabolic profiling study of shikonin's cytotoxic activity in the Huh7 human hepatoma cell line.Gene editing technology as an approach to the treatment of liver diseases.Plasmodium meets AAV-the (un)likely marriage of parasitology and virology, and how to make the match.Development of novel AAV serotype 6 based vectors with selective tropism for human cancer cells.Development of Optimized AAV Serotype Vectors for High-Efficiency Transduction at Further Reduced DosesIdentification of an adeno-associated virus binding epitope for AVB sepharose affinity resinHNF-4alpha Negatively Regulates Hepcidin Expression Through BMPR1A in HepG2 Cells.
P2860
Q26772315-BAE205B7-3F18-4923-AD77-230B4D1BA5FEQ28085748-EFA80085-E8CC-48FA-8DCA-A165CE692EE2Q33623549-104DEDA4-E4AF-4B04-B45C-0E42A155FE82Q35110143-B8DBBE58-B8A4-404E-A4A4-0D1762745C8EQ36427096-F7694989-4180-4133-9974-AECE961F918CQ36427105-F4024ECF-A814-4471-8835-AEC9ADD50189Q36867801-BCAD4CD8-B412-4EC5-9FB9-981535E1AF0FQ37043507-019BB484-F167-4456-9A63-E24554BE0666Q38706321-1E8159C8-9F4F-4425-8D6B-CBABCF6A3EFDQ38713398-1EC754AF-C9C6-4D4E-BC33-EB7CD19F5E3DQ38749884-547C3CB1-CDB4-4DEC-B307-E290A1F3D2A0Q38818422-C213FD72-93E5-4A2E-B875-1052AC018D9BQ38843995-A51614F7-E30F-41DD-A8C9-B6D148CB14E7Q40644650-ACAB855C-91CE-4327-A676-5AE4051BC2ACQ41098235-F366B95B-5A39-4D68-9E5E-B5A537D478E1Q51454017-4D7A13BF-93E2-4A01-9D96-F2C55D594B5D
P2860
Selective in vivo targeting of human liver tumors by optimized AAV3 vectors in a murine xenograft model
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Selective in vivo targeting of ...... rs in a murine xenograft model
@ast
Selective in vivo targeting of ...... rs in a murine xenograft model
@en
Selective in vivo targeting of ...... rs in a murine xenograft model
@nl
type
label
Selective in vivo targeting of ...... rs in a murine xenograft model
@ast
Selective in vivo targeting of ...... rs in a murine xenograft model
@en
Selective in vivo targeting of ...... rs in a murine xenograft model
@nl
prefLabel
Selective in vivo targeting of ...... rs in a murine xenograft model
@ast
Selective in vivo targeting of ...... rs in a murine xenograft model
@en
Selective in vivo targeting of ...... rs in a murine xenograft model
@nl
P2093
P2860
P356
P1433
P1476
Selective in vivo targeting of ...... rs in a murine xenograft model
@en
P2093
Anila Ejjigani
Arun Srivastava
Changquan Ling
George V Aslanidi
Guangping Gao
P2860
P304
P356
10.1089/HUM.2014.099
P577
2014-12-01T00:00:00Z